PATENT CLAIM ANALYSIS

Application Number: 15766395
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "211150"]

Abstract:
The present invention relates to oxazolidinone compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, E, and R1 are as defined herein. The present invention also relates to compositions which comprise at least one oxazolidinone compound of the invention. The invention also provides methods for inhibiting growth of mycobacterial cells as well as a method of treating mycobacterial infections by  Mycobacterium tuberculosis  comprising administering a therapeutically effective amount of an oxazolidinone of the invention and/or a pharmaceutically acceptable salt thereof, or a composition comprising such compound and/or salt.

Claim (Index 10):
The compound of  claim 9 , or a pharmaceutically acceptable salt thereof, having the structure:

Metadata:
- Claim Count in Document: 6.0
- Percentile: 91.0
- Lexical Diversity: 1.5873
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15517570', '15910571', '15309533', '15738503', '11655840']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8142203730456418
- 35 USC 102 Novelty (BERT): 0.5208286006351535
- Combined Prediction Score: 0.7848811958045929
- Mean Citation Score: 330.851608
- Max Citation Score: 338.07108
- Similarity Product: 308.1805365978313

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test